Study of changes in lipoprotein (a) level in streptozotocin-induced diabetic rats treated with aqueous extract of berberis vulgaris

Background & Objective: Dyslipidemia increases the risk of developing cardiovascular diseases in diabetic patients. Lipoprotein a, as a cholesterol carrier and competitive inhibitor of plasminogen in the blood coagulation system is considered an atherogenic factor which increases the risk of dev...

Full description

Bibliographic Details
Main Authors: Mina Hemmati, Elham Zohoori, Somayeh Asghari
Format: Article
Language:English
Published: Golestan University of Medical Sciences 2014-04-01
Series:Jorjani Biomedicine Journal
Subjects:
Online Access:http://goums.ac.ir/jorjanijournal/browse.php?a_code=A-10-24-43&slc_lang=en&sid=1
_version_ 1819123631040495616
author Mina Hemmati
Elham Zohoori
Somayeh Asghari
author_facet Mina Hemmati
Elham Zohoori
Somayeh Asghari
author_sort Mina Hemmati
collection DOAJ
description Background & Objective: Dyslipidemia increases the risk of developing cardiovascular diseases in diabetic patients. Lipoprotein a, as a cholesterol carrier and competitive inhibitor of plasminogen in the blood coagulation system is considered an atherogenic factor which increases the risk of developing atherosclerosis in diabetic individuals. Based on previous studies, Barberry is thought to lower cholesterol and triglyceride levels. Since increased cholesterol level, especially Lipoprotein a, increases the risk of cardiovascular diseases in people with diabetes, the aim of this study was to evaluate serum levels of Lipoprotein (a) in diabetic rats treated with aqueous extract of Barberry. Method: In this experimental study, diabetes was induced in 15 mice by intraperitoneal injection of streptozotocin (STZ) and then they were treated orally for 14 days with liquid extract of the said plant in doses of 25 and 100 mg/kg. At the end of the treatment period, mice were kept fasted for 12 hours and then by heart phlebotomy, serum levels of Lipoprotein a, serum levels of glucose, triglycerides, total cholesterol, HDL and LDL were measured in normal and diabetic groups. The results were then analyzed using SPSS version 16, ANOVA and Tukey›s test. Results: Data analysis showed that the consumption of both oral doses of Berberis vulgaris (Barberry) in diabetic rats causes a significant reduction in serum levels of triglyceride, serum glucose and VLDL(P=0.01). The extract at both used doses also significantly reduced serum levels of lipoprotein (a) in treated diabetic rats (P=0.012). Conclusion: Oral administration of the aqueous extract of Berberis vulgaris (Barberry) is effective for reducing triglyceride and glucose levels in diabetic mice. Since Barberry lowers Lipoprotein (a) levels, it can be considered as an anti-atherogenic factor.
first_indexed 2024-12-22T07:11:25Z
format Article
id doaj.art-fced489c131241b3ab8e17802408b472
institution Directory Open Access Journal
issn 2645-3509
language English
last_indexed 2024-12-22T07:11:25Z
publishDate 2014-04-01
publisher Golestan University of Medical Sciences
record_format Article
series Jorjani Biomedicine Journal
spelling doaj.art-fced489c131241b3ab8e17802408b4722022-12-21T18:34:31ZengGolestan University of Medical SciencesJorjani Biomedicine Journal2645-35092014-04-01211711Study of changes in lipoprotein (a) level in streptozotocin-induced diabetic rats treated with aqueous extract of berberis vulgarisMina Hemmati0Elham Zohoori1Somayeh Asghari2 Birjand University of Medical Sciences Birjand University of Medical Sciences Birjand University of Medical Sciences Background & Objective: Dyslipidemia increases the risk of developing cardiovascular diseases in diabetic patients. Lipoprotein a, as a cholesterol carrier and competitive inhibitor of plasminogen in the blood coagulation system is considered an atherogenic factor which increases the risk of developing atherosclerosis in diabetic individuals. Based on previous studies, Barberry is thought to lower cholesterol and triglyceride levels. Since increased cholesterol level, especially Lipoprotein a, increases the risk of cardiovascular diseases in people with diabetes, the aim of this study was to evaluate serum levels of Lipoprotein (a) in diabetic rats treated with aqueous extract of Barberry. Method: In this experimental study, diabetes was induced in 15 mice by intraperitoneal injection of streptozotocin (STZ) and then they were treated orally for 14 days with liquid extract of the said plant in doses of 25 and 100 mg/kg. At the end of the treatment period, mice were kept fasted for 12 hours and then by heart phlebotomy, serum levels of Lipoprotein a, serum levels of glucose, triglycerides, total cholesterol, HDL and LDL were measured in normal and diabetic groups. The results were then analyzed using SPSS version 16, ANOVA and Tukey›s test. Results: Data analysis showed that the consumption of both oral doses of Berberis vulgaris (Barberry) in diabetic rats causes a significant reduction in serum levels of triglyceride, serum glucose and VLDL(P=0.01). The extract at both used doses also significantly reduced serum levels of lipoprotein (a) in treated diabetic rats (P=0.012). Conclusion: Oral administration of the aqueous extract of Berberis vulgaris (Barberry) is effective for reducing triglyceride and glucose levels in diabetic mice. Since Barberry lowers Lipoprotein (a) levels, it can be considered as an anti-atherogenic factor.http://goums.ac.ir/jorjanijournal/browse.php?a_code=A-10-24-43&slc_lang=en&sid=1DiabetesTriglycerideLipoprotein aBerberis vulgarisSerum glucose level
spellingShingle Mina Hemmati
Elham Zohoori
Somayeh Asghari
Study of changes in lipoprotein (a) level in streptozotocin-induced diabetic rats treated with aqueous extract of berberis vulgaris
Jorjani Biomedicine Journal
Diabetes
Triglyceride
Lipoprotein a
Berberis vulgaris
Serum glucose level
title Study of changes in lipoprotein (a) level in streptozotocin-induced diabetic rats treated with aqueous extract of berberis vulgaris
title_full Study of changes in lipoprotein (a) level in streptozotocin-induced diabetic rats treated with aqueous extract of berberis vulgaris
title_fullStr Study of changes in lipoprotein (a) level in streptozotocin-induced diabetic rats treated with aqueous extract of berberis vulgaris
title_full_unstemmed Study of changes in lipoprotein (a) level in streptozotocin-induced diabetic rats treated with aqueous extract of berberis vulgaris
title_short Study of changes in lipoprotein (a) level in streptozotocin-induced diabetic rats treated with aqueous extract of berberis vulgaris
title_sort study of changes in lipoprotein a level in streptozotocin induced diabetic rats treated with aqueous extract of berberis vulgaris
topic Diabetes
Triglyceride
Lipoprotein a
Berberis vulgaris
Serum glucose level
url http://goums.ac.ir/jorjanijournal/browse.php?a_code=A-10-24-43&slc_lang=en&sid=1
work_keys_str_mv AT minahemmati studyofchangesinlipoproteinalevelinstreptozotocininduceddiabeticratstreatedwithaqueousextractofberberisvulgaris
AT elhamzohoori studyofchangesinlipoproteinalevelinstreptozotocininduceddiabeticratstreatedwithaqueousextractofberberisvulgaris
AT somayehasghari studyofchangesinlipoproteinalevelinstreptozotocininduceddiabeticratstreatedwithaqueousextractofberberisvulgaris